封面
市場調查報告書
商品編碼
2054509

智慧吸入器市場:按產品、銷售管道和地區分類

Smart Inhalers Market, By Product, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,智慧吸入器市場規模將達到14.883億美元,2033年將達到375.676億美元。預計從2026年到2033年,其複合年成長率將達到58.6%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 14.883億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 58.60% 2033年市場規模預測: 375.676億美元

智慧吸入器是醫療設備,它可以透過藍牙等方式與行動應用程式連接。這些設備配備了感測器技術,可以幫助記錄使用日期、時間以及患者使用時的位置等數據。

市場動態

呼吸系統疾病的日益普及、全球人口老化、新冠肺炎疫情的全球蔓延以及智慧吸入器需求的成長和普及,預計將成為推動全球智慧吸入器市場成長的關鍵因素。例如,2023年1月,Aseptika以其為肺病患者開發的「智慧吸入器追蹤器」榮獲英國創新署智慧獎。這項「智慧獎」將助力該公司開發第三代智慧吸入器追蹤器,該追蹤器整合了5G行動通訊功能。這將使患者無需再透過智慧型手機向其臨床團隊、看護者或父母發送數據,訊息將透過無線電波直接髮送到公司的雲端資料庫。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數,對全球智慧吸入器市場的主要參與者進行了分析。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球智慧吸入器市場報告的目標受群眾外包括行業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過對全球智慧吸入器市場進行分析時所使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 呼吸系統疾病盛行率增加
    • 智慧吸入器的認知度低且高成本
    • 智慧吸入器的需求和普及程度不斷提高
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球智慧吸入器市場:按類型分類,2021-2033年

  • 吸入器
  • 噴霧器

第5章 全球智慧吸入器市場:依通路分類,2021-2033年

  • 醫院
  • 藥局

第6章 全球智慧吸入器市場:依地區分類,2021-2033年

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第7章 競爭情勢

  • Adherium Limited
  • AstraZeneca
  • Boehringer Ingelheim
  • Cohero Health
  • GSK
  • Novartis
  • ResMed

第8章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI5738

Smart Inhalers Market is estimated to be valued at USD 1488.3 Mn in 2026 and is expected to reach USD 37,567.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 58.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1488.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 58.60% 2033 Value Projection: USD 37,567.6 Mn

A smart inhaler is a medical device that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use.

Market Dynamics

Rise in prevalence of respiratory disorders, growing geriatric (aging) population around the world, the outbreak of COVID-19 across the globe, and increasing demand/adoption of smart inhalers are major factors expected to drive growth of the global smart inhalers market. For instance, In January 2023, Aseptika won an Innovate UK Smart Award to develop a Smart Inhaler Tracker for patients with lung health conditions. The Smart Award will help the company develop its third-generation smart inhaler tracker, which will have 5G mobile connectivity built-in. This means that patients will no longer have to send their data via a smartphone to their clinical teams, carers, or parent; it will just send information over the airwaves directly to the company's cloud databases.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global smart inhalers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GSK, Novartis, and ResMed, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global smart inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart inhalers market.

Market Segmentation

  • Global Smart Inhalers Market, By Product (Revenue, USD Mn, 2021 - 2033)
  • Inhalers
  • Metered Dosage Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers
  • Global Smart Inhalers Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Pharmacies
  • Global Smart Inhalers Market, By Geography (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Companies Insights
  • Adherium Limited
  • AstraZeneca
  • Boehringer Ingelheim
  • Cohero Health
  • GSK
  • Novartis
  • ResMed

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Distribution channel
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in prevalence of respiratory disorders
    • Lack of awareness and high cost of smart inhalers
    • Increasing demand/adoption of smart inhalers
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Smart Inhalers Market, By Type, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
      • Metered Dosage Inhalers (MDIs)
      • Dry Powder Inhalers (DPIs)
  • Nebulizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

5. Global Smart Inhalers Market, By Distribution channel, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
  • Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

6. Global Smart Inhalers Market, By Geography, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033 (USD Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033 (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033 (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033 (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2021 - 2033 (USD Mn)
      • Middle East
      • Africa

7. Competitive Landscape

  • Adherium Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cohero Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GSK
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ResMed
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About us